Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study history's revision label was updated from v3.6.4 to v3.6.5, indicating a new platform revision for the page.
    Difference
    0.1%
    Check dated 2026-08-09T17:09:42.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    On 2026-07-21, the page adds new sections for Study Status and Study Identification and updates the revision to v3.6.4. The earlier v3.6.3 revision was removed on 2026-07-10.
    Difference
    0.5%
    Check dated 2026-07-25T07:45:42.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    New sections for Study Status and Study Identification were added to the study history on 2026-07-10 and 2026-07-08, representing updates to the trial’s current status and identifying details; a deletion was recorded on 2026-06-29.
    Difference
    0.4%
    Check dated 2026-07-10T22:52:15.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    This update adds several core study sections (Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Description, Sponsor/Collaborators, Study Status) and introduces Revision: v3.6.3 (version 14) to the record, reflecting expanded study detail.
    Difference
    1.0%
    Check dated 2026-07-03T20:09:39.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The record history now shows a new revision tag (v3.6.2), replacing the previous v3.6.0, indicating the study record has been updated.
    Difference
    0.1%
    Check dated 2026-06-26T23:48:31.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    The newer version deletes several core study-record sections (Contacts/Locations, Study Status, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Conditions, Study Description, Oversight, Study Identification, Recruitment Status) that together define how the trial is conducted and presented.
    Difference
    11%
    Check dated 2026-06-19T23:01:33.000Z thumbnail image

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.